Micro Learning: Get to know! Long-Acting Injectable PrEP and HIV Treatment
Resource updated 12/19/2023
Resource updated 12/19/2023
Resource updated 10/18/2023
Resource updated 05/10/2023
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource updated 06/06/2023
Resource updated 09/18/2023
Resource (Conference Presentation) updated 09/14/2023
Resource updated 06/27/2024
Resource from the RWHAP Best Practices Compilation updated on 05/20/2024
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
RWHAP Technical Assistance Provider updated on 07/09/2024
Resource updated 05/15/2024
RWHAP Technical Assistance Provider updated on 03/04/2024
Resource from the RWHAP Best Practices Compilation updated on 05/20/2024
Resource updated 04/10/2023
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource updated 04/06/2023
We analyzed variation in service use and associations between service use and viral suppression by race/ethnicity. Results can be used to identify areas for potential quality improvement.
Resource (Conference Presentation) updated 09/14/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023